Median Craniofacial Dysplasia: Operative Decision-Making Guided by Tissue Substrate
1Department of Plastic Surgery, Faculty of Medicine, Sohag University, Sohag, Egypt.
Annals of Plastic Surgery
|August 7, 2026
Summary
Median craniofacial dysplasia management can be improved by considering tissue substrate (hypoplasia, dysraphia, hyperplasia) alongside anatomy. This approach guides operative timing and staging for better outcomes.
Area of Science:
- Craniofacial surgery
- Pediatric plastic surgery
- Congenital anomalies
Background:
- Median craniofacial dysplasia presents as a rare, heterogeneous group of midline deformities.
- Existing classifications lack practical guidance for operative decision-making.
- Observed patterns suggest a mismatch between operative strategy and tissue substrate.
Purpose of the Study:
- To develop a conceptual operative framework for median craniofacial dysplasia.
- To derive principles for operative intent, timing, and staging.
- To improve reconstructive strategies based on longitudinal experience.
Main Methods:
- Retrospective observational case series of median craniofacial dysplasia.
- Categorization of deformities into deficiency (hypoplasia), dysraphia, and hyperplasia.
- Derivation of operative principles from clinical observations.
Main Results:
- Distinct reconstructive patterns emerged across different tissue substrates.
- Hypoplastic deformities showed progressive nasal narrowing post-intervention.
- Dysraphic deformities maintained stability after early reapproximation; hyperplastic deformities required staged reduction.
Conclusions:
- A tissue substrate-based approach offers a more useful framework than anatomy alone for median craniofacial dysplasia.
- This framework aids operative reasoning, particularly when anatomy is insufficient for guiding timing or staging.
- It provides a hypothesis-generating tool for complex cases.
